Skip to main content
OpenTrials

Clinical trial condition

Hyperphosphatemia

Explore clinical trials studying Hyperphosphatemia. Study availability and eligibility vary by location and protocol.

95 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Hyperphosphatemia trial results

Completed

Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients

NCT01069692

Conditions
Chronic Disease, Chronic Kidney Disease, Disease Attributes, +14 more
Locations
  • Novartis Investigative Site Jette, Belgium
  • Novartis Investigative Site Liège, Belgium
  • Novartis Investigative Site Roeselare, Belgium
  • Novartis Investigative Site Brescia, Italy
View Trial Details
Completed

Dose Finding Study to Treat High Phosphate Levels in the Blood.

NCT02081534

Conditions
Chronic Disease, Disease Attributes, Female Urogenital Diseases, +14 more
Locations
  • Research Site Downey, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Sacramento, California, United States
  • Research Site Whittier, California, United States
View all 41 locations
View Trial Details
Completed

An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)

NCT02675998

Conditions
Hyperphosphatemia, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
Locations
  • Ardelyx Investigative Site 429 Huntsville, Alabama, United States
  • Ardelyx Investigative Site 425 Riverside, California, United States
  • Ardelyx Clinical Site 403 Denver, Colorado, United States
  • Ardelyx Investigative Site 410 Lauderdale Lakes, Florida, United States
View all 32 locations
View Trial Details
Completed

Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis

NCT03256838

Conditions
Chronic Disease, Disease Attributes, End-stage Renal Disease, +15 more
Locations
  • Division of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang-Gung Memorial Hospital Kaohsiung City, Taiwan
  • Division of Nephrology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital Keelung, Taiwan
  • Division of Nephrology, Department of Internal Medicine, Far East Memorial Hospital New Taipei City, Taiwan
View Trial Details
Completed

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal Disease

NCT01503736

Conditions
Chronic Disease, Disease Attributes, ESRD, +16 more
Locations
  • Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang-Gung Memorial Hospital Kaohsiung City, Taiwan
  • Division of Nephrology, Keelung Chang Gung Memorial Hospital Keelung, Taiwan
  • Division of Nephrology, Department of Internal Medicine, Far East Memorial Hospital New Taipei City, Taiwan
  • Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital Taichung, Taiwan
View Trial Details
Completed

Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD)

NCT02687594

Conditions
Hyperphosphatemia, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
Locations
  • Centre Hospitalier LYON-SUD Pierre-Bénite, France
  • Klinikum Coburg Coburg, Germany
  • General Hospital of Athens Laiko Athens, Greece
  • Ospedale Maggiore Policlinico Milan, Italy
View Trial Details

Related conditions